MedPath

Trivora

Trivora-28 (levonorgestrel and ethinyl estradiol tablets USP) triphasic regimen

Approved
Approval ID

45293c33-9f32-46c8-a8ec-07a0fb8b7c4f

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 3, 2022

Manufacturers
FDA

Mayne Pharma Inc.

DUNS: 867220261

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Levonorgestrel and Ethinyl Estradiol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51862-510
Application NumberANDA074538
Product Classification
M
Marketing Category
C73584
G
Generic Name
Levonorgestrel and Ethinyl Estradiol
Product Specifications
Effective DateMarch 3, 2022
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Trivora - FDA Drug Approval Details